[go: up one dir, main page]

HN2002000334A - Procedimiento para la preparacion de derivados biciclicos sustituidos para el tratamiento del crecimiento celular anormal - Google Patents

Procedimiento para la preparacion de derivados biciclicos sustituidos para el tratamiento del crecimiento celular anormal

Info

Publication number
HN2002000334A
HN2002000334A HN2002000334A HN2002000334A HN2002000334A HN 2002000334 A HN2002000334 A HN 2002000334A HN 2002000334 A HN2002000334 A HN 2002000334A HN 2002000334 A HN2002000334 A HN 2002000334A HN 2002000334 A HN2002000334 A HN 2002000334A
Authority
HN
Honduras
Prior art keywords
preparation
treatment
cell growth
procedure
abnormal cell
Prior art date
Application number
HN2002000334A
Other languages
English (en)
Inventor
Carlos Roberts Avalos
Original Assignee
Carlos Roberts Avalos
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carlos Roberts Avalos filed Critical Carlos Roberts Avalos
Publication of HN2002000334A publication Critical patent/HN2002000334A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/027—Organoboranes and organoborohydrides

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

la presente invencion se refiere a procedimiento para la preparacion de derivados biciclicos sustituidos para el tratamiento del crecimiento celular anormal
HN2002000334A 2001-11-30 2002-11-27 Procedimiento para la preparacion de derivados biciclicos sustituidos para el tratamiento del crecimiento celular anormal HN2002000334A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33464701P 2001-11-30 2001-11-30

Publications (1)

Publication Number Publication Date
HN2002000334A true HN2002000334A (es) 2003-02-21

Family

ID=23308141

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2002000334A HN2002000334A (es) 2001-11-30 2002-11-27 Procedimiento para la preparacion de derivados biciclicos sustituidos para el tratamiento del crecimiento celular anormal

Country Status (28)

Country Link
US (1) US20030144506A1 (es)
EP (1) EP1448551B1 (es)
JP (1) JP4220388B2 (es)
KR (1) KR20040054813A (es)
CN (1) CN1639149A (es)
AR (1) AR037591A1 (es)
AT (1) ATE377009T1 (es)
AU (1) AU2002337428A1 (es)
BR (1) BR0214606A (es)
CA (1) CA2462149C (es)
DE (1) DE60223279T2 (es)
DO (1) DOP2002000519A (es)
ES (1) ES2295409T3 (es)
GT (1) GT200200245A (es)
HN (1) HN2002000334A (es)
HU (1) HUP0500117A3 (es)
IL (1) IL160971A0 (es)
MX (1) MXPA04005157A (es)
PA (1) PA8558601A1 (es)
PE (1) PE20030643A1 (es)
PL (1) PL370911A1 (es)
RS (1) RS44004A (es)
RU (1) RU2004116345A (es)
SV (1) SV2004001419A (es)
TN (1) TNSN02096A1 (es)
TW (1) TW200300691A (es)
WO (1) WO2003045939A1 (es)
ZA (1) ZA200402054B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004054585A1 (en) * 2002-12-18 2004-07-01 Pfizer Products Inc. 4-anilino quinazoline derivatives for the treatment of abnormal cell growth
MXPA05006582A (es) * 2002-12-19 2005-08-16 Pfizer Prod Inc Complejos de e-2-metoxi -n-(3 -{4-[3 -metil-4 -(6-metilpiridin -3- iloxi) fenilamino] quinazolin -6-il} alil) acetamida, su procedimiento de produccion y uso.
AU2004228460A1 (en) * 2003-04-09 2004-10-21 Pfizer Products Inc. Processes for the preparation of N-((((pyridinyloxy) -phenylamino) quinazolinyl)- allyl) acetamide derivatives and related compounds as well as intermediates of such processes and processes for the preparation of such intermediates
US8309562B2 (en) 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
CN1984660B (zh) * 2003-07-03 2010-12-15 美瑞德生物工程公司 作为天冬氨酸特异性半胱氨酸蛋白酶活化剂和细胞程序死亡诱导剂的4-芳基氨基-喹唑啉
US20050192298A1 (en) * 2004-02-27 2005-09-01 Pfizer Inc Crystal forms of E-2-Methoxy-N-(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide
SI1746999T1 (sl) 2004-05-06 2012-01-31 Warner Lambert Co 4-fenilamino-kinazolin-6-il-amidi
US8258145B2 (en) 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
CA2592900A1 (en) 2005-01-03 2006-07-13 Myriad Genetics Inc. Nitrogen containing bicyclic compounds and therapeutical use thereof
NZ569525A (en) * 2005-12-02 2010-09-30 Paper Products Ltd Holographic flexible tube laminate for packaging and method of making the same
MX2021003517A (es) 2018-09-25 2021-08-16 Black Diamond Therapeutics Inc Composiciones de inhibidor de tirosina quinasa, metodos de fabricacion y metodos de uso.
CA3150701A1 (en) 2019-08-15 2021-02-18 Black Diamond Therapeutics, Inc. Alkynyl quinazoline compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW321649B (es) * 1994-11-12 1997-12-01 Zeneca Ltd
DE19501481A1 (de) * 1995-01-19 1996-07-25 Bayer Ag 2,8-Disubstituierte Chinazolinone
GB9603095D0 (en) * 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline derivatives
UA71945C2 (en) * 1999-01-27 2005-01-17 Pfizer Prod Inc Substituted bicyclic derivatives being used as anticancer agents
JP4044839B2 (ja) * 2000-06-22 2008-02-06 ファイザー・プロダクツ・インク 異常細胞増殖を治療するための置換２環式誘導体

Also Published As

Publication number Publication date
ATE377009T1 (de) 2007-11-15
SV2004001419A (es) 2004-02-24
PE20030643A1 (es) 2003-07-23
US20030144506A1 (en) 2003-07-31
TW200300691A (en) 2003-06-16
TNSN02096A1 (en) 2005-12-23
ES2295409T3 (es) 2008-04-16
PA8558601A1 (es) 2003-06-30
PL370911A1 (en) 2005-05-30
WO2003045939A1 (en) 2003-06-05
BR0214606A (pt) 2004-09-14
CN1639149A (zh) 2005-07-13
HUP0500117A3 (en) 2008-03-28
GT200200245A (es) 2003-09-24
JP4220388B2 (ja) 2009-02-04
EP1448551A1 (en) 2004-08-25
RS44004A (sr) 2006-10-27
JP2005515986A (ja) 2005-06-02
MXPA04005157A (es) 2004-08-11
KR20040054813A (ko) 2004-06-25
AU2002337428A1 (en) 2003-06-10
CA2462149C (en) 2010-06-22
DE60223279T2 (de) 2008-05-29
DOP2002000519A (es) 2003-05-31
CA2462149A1 (en) 2003-06-05
ZA200402054B (en) 2005-05-23
RU2004116345A (ru) 2005-03-27
IL160971A0 (en) 2004-08-31
DE60223279D1 (de) 2007-12-13
EP1448551B1 (en) 2007-10-31
HUP0500117A2 (hu) 2005-05-30
AR037591A1 (es) 2004-11-17

Similar Documents

Publication Publication Date Title
HN2003000422A (es) Derivados de pirimidina para el tratamiento del crecimiento celular anormal.
IL182488A0 (en) Sulfonamide peri-substituted bicyclics for occlusive artery disease
IL162461A0 (en) Polymorphs of clopidogrel hydrogensulfate
BRPI0414598A (pt) indóis substituìdos
ECSP034924A (es) Derivados sustituidos del 1-oxa-2,8-daza-espiro[4,5]dec-2-eno
ECSP066447A (es) Derivados de isoquinolina 1,4-disustituida como inhibidores raf-quinasa útiles para el tratamiento de enfermedades proliferativas
DOP2003000566A (es) Cicloalcanindoles con sustitución con fluor, composiciones que contienen estos compuestos y metodos de preparación para un medicamento
HN2002000334A (es) Procedimiento para la preparacion de derivados biciclicos sustituidos para el tratamiento del crecimiento celular anormal
HN2002000067A (es) Inhibidores de la rho - quinasa.
PA8523001A1 (es) Derivados de la 3-indolil-4-fenil-1h-pirrol-2,5-diona como inhibidores de glicogeno sintasa quinasa-3b
PA8539201A1 (es) Pirido-pirimidinas 6-sustituidas
JO2764B1 (en) Indole derivatives or benzimidazole derivatives to modify the enzyme AKP kinase
CR6736A (es) 5-alquilpirido[2,3-d[ piridinas como inhibidores de tirosina kinasa
ECSP055864A (es) Derivados sustituidos del pirrolo-pirazol como inhibidores de la quinasa
PA8593001A1 (es) Derivados de pirimidina para el tratamiento del crecimiento celular anormal
IL182489A0 (en) Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease
BR122018009866B8 (pt) métodos para preparar compostos de éter aminocicloexílico e compostos intermediários
MX2007011695A (es) Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos.
PA8678901A1 (es) Derivados de quinolina como agentes antibacteriales
BR0308184A (pt) Composição oftálmica compreendendo ascomicina
DOP2006000017A (es) Pirazolopiridinas y sales de las mismas, una composición farmaceútica que comprende dichos compuestos, un método para prepararlos y su uso
MX2007011698A (es) Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos.
ECSP024377A (es) Derivados de benzo (g) quinolina
GT200300287A (es) Complejos de e-2-metoxi-n-(3-{4-[3-metil-4-(6-metilpiridin-3-iloxi) fenilamino]quinazolin-6-il}alil)acetamida,suprocedimiento de produccion y uso
HN2001000125A (es) Derivados biciclicos sustituidos para el tratamiento del crecimiento celular anormal